Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 214,266 | 202,127 | 180,855 | 156,797 | 137,785 |
| Cost of Goods | 20,796 | 20,945 | 20,257 | 18,603 | 17,868 |
| Gross Profit | 193,470 | 181,182 | 160,598 | 138,194 | 119,917 |
| Operating Expenses | 164,999 | 162,359 | 136,834 | 118,637 | 107,513 |
| Operating Income | 29,267 | 19,768 | 24,021 | 20,160 | 13,272 |
| Other Income | 3,414 | 3,501 | 3,136 | 2,717 | 2,293 |
| Pre-tax Income | 32,681 | 23,269 | 27,157 | 22,877 | 15,565 |
| Income Tax | 10,089 | 9,070 | 8,722 | 5,045 | 7,026 |
| Net Income Continuous | 22,592 | 14,199 | 18,435 | 17,832 | 8,539 |
| Net Income | $22,592 | $14,199 | $18,435 | $17,832 | $8,539 |
| EPS Basic Total Ops | 0.30 | 0.19 | 0.25 | 0.24 | 0.12 |
| EPS Basic Continuous Ops | 0.30 | 0.19 | 0.25 | 0.24 | 0.12 |
| EPS Diluted Total Ops | 0.27 | 0.18 | 0.23 | 0.23 | 0.11 |
| EPS Diluted Continuous Ops | 0.27 | 0.18 | 0.23 | 0.23 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 0.27 | 0.17 | 0.23 | 0.23 | 0.11 |
| EBITDA(a) | $29,735 | $20,235 | $24,405 | $20,518 | $13,617 |